Collaboration with the private sector could what our health system needs, provided these conversations include private health funders and lead to meaningful legislative amendment and policy direction.
The US government is throwing its weight behind African production of antiretroviral drugs as the continent grapples with the world’s largest HIV epidemic.
South Africa's Health Department seeks affordable CAB-LA prices following a US donation, aiming to ensure sustainable access to this long-acting HIV prevention injection and reduce new infections across the country.
The medical schemes regulator is appealing a court decision to remove curatorship from Medipos, citing financial instability and governance issues.
A new HIV prevention drug, lenacapavir, has shown 100% protection in trials, offering hope for young women in Africa. Professor Linda-Gail Bekker believes it could be a game-changer in HIV prevention.
Women in SA face higher HIV rates due to early sexual activity, low condom use, and multiple partners. Activists urge targeted interventions and support.